President Trump signed Executive Order 14401, directing the FDA to fast-track review of psychedelic compounds and cutting the standard ten-to-twelve-month review down to as little as one to two months via “National Priority Vouchers.”
The Corporatization of Psychedelics: FDA Fast-Tracking, Patents, and Pharma
Brand Spotlight
Follow Us
420 Singles
